CSF A β < sub > 40 < /sub > and P-Tau < sub > 181 < /sub > Might Differentiate Atypical from Typical AD Phenotypes: Preliminary Evidence

Conclusions: The present study delivers promising, albeit preliminary, evidence on the utility of A β40 and P-tau181 CSF biomarkers in differentiating atypical from typical A β42/40-confirmed AD phenotypes, prompting further research and confirmation on larger cohorts.Neurodegener Dis 2022;22:83 –86
Source: Neurodegenerative Diseases - Category: Neurology Source Type: research